Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

Chen‐Hua Liu, Cheng‐Yuan Peng, Chun‐Jen Liu, Chi-Yi Chen, Gin‐Ho Lo, Kuo‐Chih Tseng, Pei–Yuan Su, Wei‐Yu Kao, Ming‐Chang Tsai, Hung‐Da Tung, Hao‐Tsai Cheng, Fu‐Jen Lee, Chia‐Sheng Huang, Ke-Jhang Huang, Yu‐Lueng Shih, Sheng‐Shun Yang, Jo‐Hsuan Wu, Hsueh‐Chou Lai, Yu‐Jen Fang, Po‐Yueh Chen, Jow-Jyh Hwang, Chi-Wei Tseng, Wei‐Wen Su, Chun‐Chao Chang, Pei‐Lun Lee, Jyh-Jou Chen, Chi‐Yang Chang, Tsai‐Yuan Hsieh, Chung‐Hsin Chang, Yi‐Jie Huang, Jia‐Horng Kao